Article

Serum glycoprotein markers in non-alcoholic steato-hepatitis and hepatocellular carcinoma

2021-10-01

Abstract excerpt

Fatty liver disease progresses through stages of fat accumulation and inflammation to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis and eventually hepatocellular carcinoma (HCC). Currently available diagnostic tools for HCC lack sensitivity and specificity and deliver little value to patients. In this study, we investigated the use of circulating serum glycoproteins to identify a panel of potential...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 38cc31a3-2b82-5003-a25c-dc3de5711dd2
DOI: 10.1101/2021.09.30.462486

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Serum glycoprotein markers in non-alcoholic steato-hepatitis and hepatocellular carcinomaDOI 10.1101/2021.09.30.462486Read

Blood<i>N</i>-glycomic signature of fibrosis in MASLD shows low levels of global α2,3-sialylationSemantic proximity Read

Integrating Transcriptomics, Glycomics And Glycoproteomics To Characterize Hepatitis B Virus-associated Hepatocellular CarcinomaSemantic proximity Read

A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity Read

N‐glycan fingerprint predicts alpha‐fetoprotein negative hepatocellular carcinoma: A large‐scale multicenter studySemantic proximity Read

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read

Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer PanelsSemantic proximity Read

The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic SolutionsSemantic proximity Read

Glycoprotein Disease Markers and Single Protein-omicsSemantic proximity Read

Fucosylated Glycoproteins as Markers of Liver DiseaseSemantic proximity Read

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisSemantic proximity Read

Multiomics study of nonalcoholic fatty liver diseaseSemantic proximity Read

Spatial Glyco-Codes Define Human Liver Pathology and ProgressionSemantic proximity Read